UF News

UF Health Study Will Examine Drugs To Treat Coronavirus UK Variant

Researchers say they aren't surprised by the coronavirus's ability to mutate, but they are working on ways to stop the spread. UF Associate Professor of Pathology David A. Ostrov's discovery about the UK variant has identified 40 candidate drugs that could serve as additional tools in the fight against COVID.

Sid Martin Biotech Alum DiaCarta’s Biomarker Algorithm Predicts Response and Outcome of Chemotherapy

UF Innovate | Sid Martin Biotech alum DiaCarta Inc., a precision molecular diagnostics company with proprietary technologies for the development of novel liquid biopsy oncology tests, announced the publication of a study in Nature Scientific Reports that demonstrates the company's cfDNA biomarker algorithm could function as a prognostic biomarker and efficacy predictor for non-small cell lung cancer (NSCLC) patients.

Resilience Acquires Biologics Manufacturing Company Ology Bioservices

Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.

Get our latest news in your inbox every Monday.

* indicates required

View previous campaigns.